Home/Filings/4/0001437749-23-015127
4//SEC Filing

Ostronic Francis Patrick 4

Accession 0001437749-23-015127

CIK 0000922247other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:38 PM ET

Size

4.8 KB

Accession

0001437749-23-015127

Insider Transaction Report

Form 4
Period: 2023-05-17
Transactions
  • Award

    Common Stock

    2023-05-17+26,700249,071 total
Footnotes (1)
  • [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2022 and first quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of 1.03 per share of common stock on May 16, 2023.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001570620

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:38 PM ET
Size
4.8 KB